Sells portable, AI-powered brain MRI systems to hospitals, neurology practices and other healthcare providers.
10-K for FY2025, filed Mar 18, 2026We are an innovative health technology business with a mission to revolutionize patient care globally through accessible, affordable…View ↗
Our initial commercial focus has been in the U.S. market and with customers that use the Swoop® system inside the hospital setting…View ↗
In 2025, in connection with the introduction of our next-generation Swoop® scanner and Optive AI™ software, we expanded our commercial…View ↗
International healthcare providers through distributor relationships.View ↗
Healthcare customers pay for the Swoop system, typically with software, service and support sold separately after a one-year warranty. Devices are generally paid for when shipped, while service and support are paid for over the service period; some customers pay annually for both.
10-K for FY2025, filed Mar 18, 2026
10-K for FY2025, filed Mar 18, 2026
FY2025 revenue by product or service ↗$13.6M
10-K for FY2025, filed Mar 18, 2026
$13.6M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Device
Sold outright
10-K for FY2025, filed Mar 18, 2026 |
84%
FY2022: 77%
|
Device, FY2025
$11.4M Sources
|
Sold outright |
|
Service
Recurring
10-K for FY2025, filed Mar 18, 2026 |
16%
FY2022: 23%
|
Service, FY2025
$2.2M Sources
|
Recurring |
U.S. hospitals and neurology offices buy directly; customers in other countries buy through distributors.
10-K for FY2025, filed Mar 18, 2026In 2025, in connection with the introduction of our next-generation Swoop® scanner and Optive AI™ software, we expanded our commercial…View ↗
International healthcare providers through distributor relationships.View ↗
The Swoop® system is commercially available in the United States, Canada, United Kingdom, certain European and Middle Eastern markets…View ↗
No. It lost $35.6M in FY2025.
10-Q for Q3 FY2026, filed Nov 9, 2026
−$6MView ↗
10-Q for Q3 FY2026, filed Nov 9, 2026
Open tableView ↗
8-K, filed Nov 9, 2026
Management continues to expect revenue for the full year 2026 to be approximately $20 to $22 million, representing 55% growth at the…View ↗
8-K, filed Sep 18, 2026
Pursuant to Nasdaq Listing Rule 5810(c)(3)(A) (the “Compliance Period Rule”), the Company has been provided an initial period of 180…View ↗
Growing. Revenue grew 9.1x in 4 years, from $1.5M in FY2021 to $13.6M in FY2025, about 74% a year.
Broader customer settings
The earlier report focused on bedside use in hospitals and care facilities. The latest report adds hospital emergency departments and clinics, office-based neurology practices, and international healthcare providers reached through distributors.
10-K for FY2022, filed Mar 22, 2023 10-K for FY2025, filed Mar 18, 2026Our initial commercial focus has been in the U.S. market and with customers that use the Swoop® system inside the hospital setting…View ↗
In 2025, in connection with the introduction of our next-generation Swoop® scanner and Optive AI™ software, we expanded our commercial…View ↗
International healthcare providers through distributor relationships.View ↗
Loading...